# Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations

> **NCT00692055** · PHASE1 · COMPLETED · sponsor: **POZEN** · enrollment: 30 (actual)

## Conditions studied

- Arthritis

## Interventions

- **DRUG:** PN400
- **DRUG:** Naproxen

## Key facts

- **NCT ID:** NCT00692055
- **Lead sponsor:** POZEN
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2008-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00692055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00692055, "Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00692055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*